Searched for
PHARMA MNC
IT a tactical buy; Devarsh Vakil reveals 5 sectors worth buying as markets turn volatileLeading analyst Devarsh Vakil suggests Indian markets offer compelling buying opportunities now, with valuations correcting to attractive l...- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- PSU mutual funds see Rs 4,498 crore outflow in March: ReportPSU mutual funds saw Rs 4,498 crore in outflows in March, a mild improvement from February, according to Vallum Capital. While PSU funds po...
- Time to buy? Sunny Agrawal finds best picks across banking, pharma, capital markets & infrastructureIndian stock markets present attractive opportunities now. Investors with an 18-month outlook should consider deploying funds, especially i...
- Will they get back the lost shine? 5 MNC pharma stocks with upside potential of up to 21%There was a time when having MNC stock was a must have in one's portfolio. They reason, they were very liberal at giving bonuses, dividend ...
- Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the ...
- Why MNC pharma companies are realigning their India operationsAt a time when the local market is assuming the centre stage of the growth strategy for Indian pharma companies, multinational drugmakers a...
- Not the time for bottom fishing, you may catch falling knives: Ajay BaggaBear markets see sharp rallies. It is still time to stay on the sidelines, says the market expert.
- Hemang Jani on why telecom, pharma & penny stocks are showing momentum nowFMCG, some private sector banks and even metal names are seeing corrections.
- Aurobindo Pharma eyes European business of ApotexThe deal may be valued at around $100 million and fits in with Aurobindo’s strategic road map of upping its presence in eastern Europe thro...
- Invest 15-20% of your portfolio in select pharma stocks; MNCs can be better betsClinton is generally perceived to be negative for pharma companies on the premise that she would try to curb the profits earned by the drug...
- Buy pharma stocks on decline: Gaurang ShahMNC and pharma cos have been always robust and some of the stocks always create value in portfolio, So you should use opportunities on lowe...
- Underweight on MNC pharma stocks, prefer domestic companies: Pramerica MF"The focus is more on domestic pharma company which have a base in domestic market as well as they have base," Mantri said.
- Top three pharma MNCs Novartis, Pfizer and Abbott lose 10% in 2013Most MNCs have been facing heat due to fast expiring patents, challenges in new drug discovery and depleting product pipeline.
- Pharma MNCs run into rough weatherThe rejection of the Glivec patent has added to pharma MNCs’ woes after a slew of measures in the past one year.
- Extremely bullish on MNC pharma space: Angel BrokingOpportunity in the pharma industry is huge so probably these parent companies may get more serious because they have been so far not taking...
- Bullish on MNC pharma stocks: Rajen Shah"Well if you see MNC pharma stocks, I am bullish on MNC pharma stocks like Wyeth, Merck, Pfizer and Novartis. "
- MNCs back in control of 50% of Indian pharma marketAcquisitions to help MNCs control nearly 50% of $9.5-billion domestic retail drug market: Analysts
- Pfizer ties up with Claris for injectablesWorld No 1 pharma company Pfizer on Wednesday announced a marketing tie-up with Rs 800-crore Ahmedabad-based Claris Lifesciences, that spec...
- Local pharma cos beat MNC peersDomestic pharmaceutical shares have outperformed their multinational (MNC) counterparts in the last month, even as the MNCs have done some ...
Load More
